Clinical Trials Directory

Trials / Completed

CompletedNCT04503122

Baroreflex Sensitivity in Patients Undergoing Ablation of Atrial Fibrillation

Baroreflex Sensitivity in Patients Undergoing Atrial Fibrillation Ablation: Association With Arrhythmia Recurrences

Status
Completed
Phase
Study type
Observational
Enrollment
116 (actual)
Sponsor
Poitiers University Hospital · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

Atrial fibrillation is the most common arrhythmia. The posterior surface of the left atrium is covered by an extensive network belonging to the autonomic nervous system that can be damaged during the ablation. The involvement of the autonomous nervous system in the genesis and maintenance of atrial fibrillation remains poorly understood. Baroreflex sensitivity is a non-invasive method assessing autonomous nervous system activity. The rate of atrial fibrillation recurrence after ablation is currently high and a better understanding of the mechanisms associated with recurrence is essential to improve selection of the patients who will benefit the most from this procedure. The aim of this study is to evaluate the association between the baroreflex sensitivity and atrial fibrillation recurrences and to analyze the prognostic contribution of the baroreflex measurement compared to other published criteria.

Conditions

Interventions

TypeNameDescription
PROCEDUREpulmonary vein isolationpulmonary vein isolation : cryoablation or radiofrequency

Timeline

Start date
2021-06-22
Primary completion
2025-11-13
Completion
2025-11-13
First posted
2020-08-07
Last updated
2025-12-24

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04503122. Inclusion in this directory is not an endorsement.